Data / Drug companies / Methylergonovine maleate
Methylergonovine maleate: 13 companies and 14 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Methylergonovine maleate is listed in the FDA National Drug Code Directory by 13 companies, with 14 products in commercial distribution. 14 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; injection; injection, solution, and the newest product started marketing on September 13, 2024.
The request: Get every company that lists methylergonovine maleate in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 13
- Products
- 14
- Generic (ANDA) products
- 14 (100.0%)
- Application numbers
- 7
- Routes
- Oral, Intravenous, Intramuscular
- Brand names
- Methergine
- openFDA record search
- api.fda.gov
Companies that list methylergonovine maleate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| HF Acquisition Co LLC, DBA HealthFirst | 2 | injection; injection, solution | Generic drugs (ANDA) | June 14, 2021 |
| American Health Packaging | 1 | tablet | Generic drugs (ANDA) | March 20, 2024 |
| American Regent, Inc. | 1 | injection, solution | Generic drugs (ANDA) | June 21, 2010 |
| Breckenridge Pharmaceutical, Inc. | 1 | injection | Generic drugs (ANDA) | November 7, 2016 |
| Bryant Ranch Prepack | 1 | injection | Generic drugs (ANDA) | November 7, 2016 |
| Bryant Ranch Prepack | 1 | injection | Generic drugs (ANDA) | November 7, 2016 |
| Granules Pharmaceuticals Inc. | 1 | tablet | Generic drugs (ANDA) | May 25, 2018 |
| Lupin Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | April 4, 2016 |
| Major Pharmaceuticals | 1 | tablet | Generic drugs (ANDA) | September 13, 2024 |
| Pharmacist Pharmaceutical, LLC | 1 | injection, solution | Generic drugs (ANDA) | November 1, 2010 |
| Rising Pharma Holdings, Inc. | 1 | tablet | Generic drugs (ANDA) | January 15, 2021 |
| Teva Pharmaceuticals USA, Inc. | 1 | tablet | Generic drugs (ANDA) | March 26, 2019 |
| Volley Pharmaceuticals, LLC | 1 | tablet | Generic drugs (ANDA) | March 15, 2024 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 7 | 50% |
| Injection | 4 | 28.6% |
| Injection, solution | 3 | 21.4% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 14 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Ergot Derivative | 14 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.